Swiss startup Limula raises $6.8M for cell therapy automation
Longevity Technology - 22-May-2024Company is aiming to increase accessibility and affordability
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Personalised cancer treatments
Limula provides an innovative solution for the production of the most personalised cancer treatments on demand and at scale. Their product is a unique proprietary platform can perform multiple steps of cell therapy manufacturing in a single device, using end-to-end automation and integrated process analytics.
Visit website: https://limula.ch/
Details last updated 26-May-2024
Company is aiming to increase accessibility and affordability